VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1279587
Sex: F
Age: 67
State:

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 02/24/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Narrative: Patient notes having rushed to the vaccination visit without eating/drinking or checking her blood sugar. After vaccination, she proceeded to go to her nephrology appointment and then to go shopping. On her way home driving (>4 hours after vaccinatino), she began to experience lightheadedness and then next remembers being surrounded by EMS and police and being told her blood pressure was low. At that time, she denies pruritus, flushing, angioedema, LOC, SOB, wheezing, palpitations, nausea or vomiting. Per chart review she was found to be driving erratically - with EMS reporting BP 60/30 initially and subsequent improvement to 80s/50s with administration of IVF. There was no LOC reported at/during the event, which was confirmed by Patient today. She notes having been observed o/n and then instructed to change some of her medications. Today, she states that she is feeling "ok". She again rushed to today's vaccination appointment, but had eaten toast and cocoa this morning. She has not yet checked her blood sugar. Discussed concerning adverse effects of vaccination, including anaphylaxis and immediate allergic reactions and ER precautions-for which she was able to state verbal understanding. She was provided with water and consumed a bag of trail mix while waiting for 30 minutes post vaccination. During the post vaccination period, she did not experience any side effects and was able to ambulate using walker out of clinic w/o difficulties.

Other Meds:

Current Illness:

ID: 1279588
Sex: M
Age:
State:

Vax Date: 02/04/2021
Onset Date: 02/08/2021
Rec V Date: 02/24/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Palpitations employee experienced afib Narrative: employee states she was hospitalized with afib but info is not available and employee has retired

Other Meds:

Current Illness:

ID: 1279611
Sex: M
Age:
State: KY

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 02/24/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: NKA

Symptom List:

Symptoms: Patient began feeling weak, passed out at home Hospitalization 2/15- 17/2021 dx. syncope & collapse has not had a reoccurrence since left hospital

Other Meds: see back

Current Illness:

ID: 1285006
Sex: F
Age:
State: CA

Vax Date: 02/15/2021
Onset Date:
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: None

Symptom List:

Symptoms: I went to the Covid vaccination site for my second dose of the Pfizer vaccine. The person administering the vaccine spilled about one-third of the dose and did not care when I pointed that out. She turned away and refused any further conversation. My primary care doctor does not have enough information to know what to do. I spent two hours on the phone calling Pfizer to try to get some guidance. At Pfizer, I spoke to someone, who refused to provide any information and simply wasted my time. I am very concerned that I did not receive a full dose and that therefore the vaccine will not be effective. Pfizer is just a brick wall and does not care what happens to patients.

Other Meds:

Current Illness: None

ID: 1285007
Sex: M
Age:
State: MA

Vax Date: 02/02/2021
Onset Date: 02/06/2021
Rec V Date: 02/24/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: None

Symptom List:

Symptoms: Diagnosed with CML few months ago and taking Dasatinib daily with great response and normalized WBCs. Had second dose of Pfizer vaccine 2/2. Blood work on 2-5 WBCs 150K and 2/6 bilateral blood clots in legs which then became pulmonary blood clots.

Other Meds: Dasatinib Cardivol BID Atorvastin 20 mg Zyrtec qd Vitamin D and B12

Current Illness:

ID: 1285008
Sex: F
Age: 20
State:

Vax Date: 02/16/2021
Onset Date:
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My 20 year old daughter had the mederna vaccine The following morning she fainted and blacked out for 4minutes She now has tiredness ,pain in her neck and swelling in her neck Heart rate increased also

Other Meds:

Current Illness:

ID: 1285009
Sex: M
Age:
State: MD

Vax Date:
Onset Date: 01/08/2021
Rec V Date: 02/24/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient was given COVID vaccine shot #1 on 1/4/2021. As of 1/8/2021 he was prohibited from donating blood due to a hemoglobin of 12.8. 2 weeks later he presented to donate again on 1/26/2021 and his hemoglobin had dropped to 7.8 without evidence of bleeding. He was subsequently admitted to hospital on 1/29/2021 - where he was found to be severely leukopenic and thrombocytopenic. A bone marrow biopsy revealed a diagnosis of severe aplastic anemia. He remains hospitalized but is now at another location. This has also been reported through VAERS.

Other Meds:

Current Illness:

ID: 1285010
Sex: F
Age: 64
State: GA

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Morphine

Symptom List:

Symptoms: Pfizer covid-19 vaccine on date above. Liver transplant 9/23/20. No signs of rejection until after the vaccine. Had to have testing and liver biopsy to determine cause of alt and ast. Results is mild rejection. Doctors still encourage 2nd dose of vaccine on 2/12/21. I am very concerned to do that.

Other Meds: Prednisone 20 mg Tacrolimus 5 mg 2x daily Zoloft 50 mg daily aspirin 81 mg daily photonics 40 mg 2xdly Valcyte 400 mg every other day zertec 10 mg daily. Trazadone 50 mg at bedtime multivitamin 1x daily Bactrim 1x daily. Novolog sliding sca

Current Illness: None

ID: 1285011
Sex: F
Age:
State: GA

Vax Date: 02/02/2021
Onset Date: 02/09/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pfizer second dose 2/2/21 baby tachycardia 2/8 decreased motion noted by mother delivered under c section one month early stiff and no gag reflex

Other Meds:

Current Illness: none

ID: 1300740
Sex: U
Age: 61
State: CA

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Latex, Sea Food, Phenobarbital,, Dilation, Depakote

Symptom List:

Symptoms: Sensitive to touch, The shosulder area is hot to touch, Nausea about 60 mintes later, Muscular pain ratating from shoulder to soine in the C5, C6 area, Headache, The next day Vomiting, Headache, tremors, fatigue,

Other Meds: Lamical, labetalol, metformin, oyridostigmine, Bromide, Cymbalta

Current Illness: Nausea

ID: 1300741
Sex: M
Age: 70
State: NE

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: NONE

Symptom List:

Symptoms: STARTED VOMITING, EXPERIENCED STOMACH PAIN, DIAGNOSES WITH ACUTE PANCREATITUS FULLY RECOVERED, HOSPITALIZED FOR 6 DAYS PROBLEM FILLING OUT #21 HOSPITALIZED FOR 6 DAYS ---------------------------------------------------------------->>

Other Meds: atorvastatin 20mg, vitamin D3, calcium, alendronate 70mg

Current Illness: NONE

ID: 1300742
Sex: F
Age: 63
State: WA

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Penicillin, Erythromycin

Symptom List:

Symptoms: Severe headache. chills, fever >101 F, nausea, exhaustion, general body aches, very sore arm at injection site for 3 days. OTC tx included Tylenol & bed rest w/lot of fluids

Other Meds: Atenolol, HCTZ, Potassium, Flovent HFA, Sertraline

Current Illness: None

ID: 1306377
Sex: F
Age: 76
State: FL

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: cipro, doxycycline, dorzolamide, vicodin, codeine, niacin, cosopt

Symptom List:

Symptoms: Pt reported feeling an "awareness" of a tongue & tingling of tongue. No other symptoms Tingling decreased after Benadryl 12.5 mg

Other Meds: Lisinopril, eyedrops, xanax, clonidine, Vit C, Calcium

Current Illness: hypertension, osteoporosis, hyper-cholesterolemia

ID: 1306378
Sex: F
Age: 85
State: FL

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: TINGLING AROUND LIPS. PT. Took BENADRYL ... FELT BETTER> WANTED TO LEAVE.

Other Meds:

Current Illness:

ID: 1306379
Sex: M
Age: 13
State: MA

Vax Date: 10/12/2018
Onset Date:
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 10/9/18- L supraclavicular nodes back 1/18/19- Nodes back- no illness or shots 3/31/19- Dizziness- fell 4/1/19- Dx HA- Dizziness- ortostatic hypotension 4/3/19- Dx syncopy 4/11/19 Dx with POTS by Cardiology 5/13/19- Exercise elevated TSH 10/11/19- HPV # 2 given 10/12/19- supraclavicular nodes back 10/22/19- Nodes gone 1/14/20 Cardiology decreased contraction 1/28/20 Neurology- ? Absence seizures

Other Meds:

Current Illness: None

ID: 1306380
Sex: F
Age: 0
State: NY

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: local reaction-lg swelling, red. Tender to touch irritable x 24 hours, crying fever 100.4

Other Meds:

Current Illness: 0

ID: 1306381
Sex: F
Age: 82
State: AR

Vax Date: 02/06/2021
Onset Date:
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Celecoxib, vasotec

Symptom List:

Symptoms: Patient called the office on 2/11/2021 and reported an occurance of shingles. She states she noticed the shingles occurance on 2/13/2021.

Other Meds:

Current Illness: H. ZoSTeR

ID: 1306383
Sex: M
Age: 71
State: MT

Vax Date: 02/09/2021
Onset Date: 02/15/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: None

Symptom List:

Symptoms: Patient received his first Pfizer COVID-19 vaccine on 2/9/21 at 2:23 pm. Patient had experienced mild respiratory symptoms the day of vaccination. Patient reported more severe respiratory distress such as tightness of chest and shortness of breath on 2/15/21. He also had a fever. Patient went to an urgent care clinic and was tested for COVID-19. He received antibiotics for possible respiratory infection. 2/17/21 patient reports improved symptoms and no fever. Client is taking antibiotics and is using supplementary oxygen with his CPAP PRN. Checked in with patient on 1/23/21 and patient has improved. Client has a productive cough and has finished his course of antibiotics.

Other Meds: Statin

Current Illness:

ID: 1399275
Sex: M
Age: 1
State: ID

Vax Date: 02/12/2021
Onset Date: 02/19/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient developed high fevers 102.7 and local reaction 1 week following vaccines. fevers lasted 3 days and Patient developed hives on 4th day once fever resolved.

Other Meds: None

Current Illness: None

ID: 1399276
Sex: F
Age: 75
State: FL

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 02/24/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: no

Symptom List:

Symptoms: Had flu-like symptoms for 24 hours. Very tires, total body aches, appetite loss. Constant headache. Took Motrin as needed, and slept in naps. Took liquids. Temp 99 degrees.

Other Meds: BP meds

Current Illness: no

ID: 1053566
Sex: F
Age: 7
State: DC

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Consumer reported developing 5-8 lesions following VARlVAX administration.; This spontaneous report was received from a nurse practitioner, referring to a 7-year-old female patient. The patient had no pertinent medical history, previous drug reactions, allergies, or concomitant medications. On 28-JAN-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, 0.5 milliliter (ml) by subcutaneous route (lot number T022315 which has been verified to be valid, expiration date reported as 30-JAN-2022, but upon internal validation established as 30-JUN-2022) (vaccination scheme and anatomical site of injection were not reported) as immunisation. Sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were not reported) was reported, however, no information was given regarding the use of it. On 28-JAN-2021, following the administration of varicella virus vaccine live (Oka/Merck) (VARIVAX), the patient developed 5-8 lesions (ill-defined disorder). The patient sought medical attention, however, no treatment was given for the event. In addition, no laboratory diagnostic studies were performed. The outcome of the event ill-defined disorder was unknown by the reporter. The causality assessment between the aforementioned event and therapy with varicella virus vaccine live (Oka/Merck) (VARIVAX), was not provided.

Other Meds:

Current Illness: Immunisation

ID: 1053567
Sex: F
Age: 49
State: NY

Vax Date: 02/01/2020
Onset Date: 02/01/2020
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Took one unrefrigerated dose of Vivotif; Spontaneous report received on 10FEB2020. A pharmacist reported that a female consumer who "took one unrefrigerated dose of Vivotif" (PT: Product storage error). The consumer was receiving Vivotif capsule for immunisation. On 04FEB2020, the consumer took the first dose of Vivotif which was refrigerated. She left the second dose unrefrigerated (left out at room temperature for over 24 hours), and took the unrefrigerated dose. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown. Company Comment: A consumer took second dose of Vivotif which was unrefrigerated (product storage error). The second dose of Vivotif was left out at the room temperature for over 24 hours. Vivotif must stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is not applicable to Vivotif.; Sender's Comments: A consumer took second dose of Vivotif which was unrefrigerated (product storage error). The second dose of Vivotif was left out at the room temperature for over 24 hours. Vivotif must stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is not applicable to Vivotif.

Other Meds:

Current Illness:

ID: 1053568
Sex: U
Age: 11
State: NY

Vax Date: 02/01/2020
Onset Date: 02/01/2020
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Took unrefrigerated doses of Vivotif; Spontaneous report received on 10FEB2020. A pharmacist reported that a consumer "took unrefrigerated doses of Vivotif" (PT: Product storage error) while being on Vivotif for immunisation. On 02FEB2020, the consumer took the first refrigerated dose of Vivotif. The consumer took the remaining three doses of Vivotif which were unrefrigerated. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown. Company Comment: A consumer took three doses of Vivotif which were unrefrigerated (product storage error). Vivotif must be stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is assessed as not applicable to Vivotif.; Sender's Comments: A consumer took three doses of Vivotif which were unrefrigerated (product storage error). Vivotif must be stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is assessed as not applicable to Vivotif.

Other Meds:

Current Illness:

ID: 1053569
Sex: U
Age: 23
State: WV

Vax Date: 02/13/2020
Onset Date: 02/13/2020
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Had eaten a full meal 40 minutes before and cookies 30 minutes after taking first dose of Vivotif; Spontaneous report received on 14FEB2020. A healthcare professional reported that a consumer "had eaten a full meal 40 minutes before and cookies 30 minutes after taking first dose of Vivotif" (PT: Product administration error). The consumer was receiving Vivotif for immunisation. On 13FEB2020, the consumer ate a full meal then took the first dose of Vivotif 40 minutes later and then ate a couple of cookies 30 minutes after that same dose. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown. Company Comment: A consumer had eaten a meal 40 minutes before taking first dose of Vivotif and also ate cookies 30 minutes after taking Vivotif first dose (product administration error). Vivotif should be taken one hour before a meal and consumer should eat or drink for at least an hour both before and after taking Vivotif dose. Considering the nature of the event, the causality of product administration error is assessed as not applicable to Vivotif.; Sender's Comments: A consumer had eaten a meal 40 minutes before taking first dose of Vivotif and also ate cookies 30 minutes after taking Vivotif first dose (product administration error). Vivotif should be taken one hour before a meal and consumer should eat or drink for at least an hour both before and after taking Vivotif dose. Considering the nature of the event, the causality of product administration error is assessed as not applicable to Vivotif.

Other Meds:

Current Illness:

ID: 1053570
Sex: U
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Completed a course of Vivotif, which was never refrigerated; Spontaneous report received on 14FEB2020. A pharmacist reported that a consumer "completed a course of Vivotif, which was never refrigerated" (PT: Product storage error). The consumer was receiving Vivotif for immunisation. The consumer had completed a course of Vivotif in October but the consumer had never refrigerated it. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown. Company Comment: A consumer completed vivotif course but vivotif was never refrigerated (product storage error). Vivotif must be stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is assessed as possible.; Sender's Comments: A consumer completed vivotif course but vivotif was never refrigerated (product storage error). Vivotif must be stored in the refrigerator at the recommended temperature. Considering the nature of the event, the causality of product storage error is assessed as possible.

Other Meds:

Current Illness:

ID: 1053571
Sex: F
Age: 28
State: FL

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Jaw pain; Syncopal episode/Syncope; Fell; Dizziness; Nausea; Felt flu-like; Injection site pain; Fatigue; Headache; Muscle pain; Chills; Fever; Felt unwell; A spontaneous report was received from a nurse concerning a female 28 year old, patient who experienced same day injection site pain, fatigue, headache, muscle pain, chills, fever, felt unwell and flu-like. On 29/Jan/2021, she developed dizziness, nausea, a syncopal episode and fell and hit her jaw, which developed into pain. . The patient's medical history was not provided. Concomitant product use was unknown by the reporter. The patient received their second dose of mRNA-1273 lot 028L20A on 28-JAN-2021. On 28-JAN-2021 approximately 1 day prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 Lot number 028L20A intramuscularly for prophylaxis of COVID-19 infection. A patient received her second dose of Moderna vaccine on 28/Jan/2021 at 8 AM, lot 028L20A. Same day at 17:00, she experienced injection site pain, fatigue, headache, muscle pain, chills, fever, felt unwell and flu-like. On 29/Jan/2021, she developed dizziness, nausea, a syncopal episode and fell and hit her jaw, which developed pain. She was seen in the emergency room (ER) and released with a diagnosis of syncope and jaw pain. Resolution dates not reported. Treatment information was not provided/unknown. The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.; Reporter's Comments: This report concerns a 28--year-old female who received Moderna's COVID-19 Vaccine (mRNA-1273), Lot # not provided, and within 2 days, experienced injection site pain, fatigue, headache, muscle pain, chills, fever, felt unwell and flu-like, dizziness, nausea, a syncopal episode and fell and hit her jaw, which developed into pain. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: MOD21-024340:Crosslinked: Same Reporter MOD21-024360:Crosslinked: Same Reporter MOD21-024368:Crosslinked: Same Reporter MOD21-024387:Crosslinked: Same Reporter MOD21-024396:Crosslinked: Same Reporter MOD21-024411:Crosslinked: Same Reporter

Other Meds:

Current Illness:

ID: 1053572
Sex: F
Age: 90
State: VT

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arrhythmias; rapid heartbeat; slight nausea; slight headache; light bothered vision for some days; mild chills; A spontaneous report was received from a retired nurse concerning herself who is 90 year old received Moderna COVID-19 vaccine and have experienced arrhythmias, rapid heartbeat, slight nausea, slight headache, some visual problems (light bothered her for some days) and mild chills. The patient has prior history of irregular heart beat . Her relevant concomitant medications were cholesterol medication, Crestor and medication for irregular heartbeat. No information on allergies. On 28-JAN-2021, prior to the onset of events, the patient received her first of two planned doses of COVID-19 vaccine intramuscularly for the prophylaxis of COVID-19 infection. On 30-JAN-2021, 2 days after her vaccination, she developed arrhythmias, rapid heartbeat, slight nausea, slight headache, some visual problems (light bothered her for some days) and mild chills. After one week she felt like no more symptoms ongoing and felt good again. She visited her physician for arrhythmias, and he said, she should keep an eye on it, but no medication yet. She is concerned about her second shot. Action taken with 2nd dose of Moderna COVID-19 vaccine was not reported. The outcome of the events, arrhythmias, rapid heartbeat, slight nausea, slight headache, visual problems and chills were resolved at the time of report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded. However, patient's advanced age and prior history of irregular heart beat are considered risk factors for arrhythmias.

Other Meds: CRESTOR

Current Illness:

ID: 1053573
Sex: U
Age:
State:

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/25/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have lost significant range of motion in my arm/shoulder; vaccine was given to high in my shoulder; Pain; A spontaneous report was received from a paramedic who was also a male patient of unknown age, who was administered Moderna's COVID-19 vaccine and experienced that the vaccine was given to high in shoulder (vaccine administered at inappropriate site), pain and lost significant range of motion in my arm/shoulder (injected limb mobility decreased). The patient's medical history was not reported. No relevant concomitant medications were reported. On 02 Feb 2021, the patient received the second dose of mRNA-1273 through an unknown route in an unknown arm for COVID-19 infection prophylaxis. On 02 Feb 2021, the patient reported that the vaccine was given to high in his shoulder and was injected into the bursa space and he had lost significant range of motion in his arm/shoulder and the pain was severe. The patient immediately obtained medical care within six hours of receiving the vaccine. The patient was admitted to an emergency room after the initial care in less than twenty-four hours and then eventually to the hospital floor. The patient's treatment included medical care. The action taken for Moderna COVID-19 vaccine was not applicable. The outcome of the events, lost significant range of motion in arm/shoulder and the pain were considered as unknown.The outcome of the event vaccine was given to high in shoulder was resolved.; Reporter's Comments: This case report concerns a male patient of unknown age who vaccine was given to high in shoulder (vaccine administered at inappropriate site) and experienced pain and lost significant range of motion in arm/shoulder for mRNA-1273, lot # unknown. The event of pain and lost significant range of motion in arm/shoulder are temporarily associated with the product use and a causal association cannot be excluded. The event of vaccine was given to high in shoulder is assessed as not applicable.

Other Meds:

Current Illness:

ID: 1053574
Sex: F
Age: 61
State: OR

Vax Date: 01/11/2021
Onset Date: 02/11/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomiting and vomit had blood in it; Bloody nose; Vomiting; A spontaneous report was received from a consumer concerning a 61-year-old, female patient who received Moderna's COVID-19 vaccine and experienced bloody nose/epistaxis, vomiting and the vomit had blood in it/ hematemesis. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 10 FEB 2021, the patient received her second planned doses of mRNA-1273 (Lot number: 032L20A) intramuscularly in the left arm and administered by medical center for prophylaxis of COVID-19 infection. On 11 FEB 2021, in the morning the patient woke up with a bloody nose, vomiting and the vomit had blood in it. The treatment information for the events, were not provided. The patient had other medicine for her blood pressure and toe fungus. The action taken with the second dose of mRNA-1273 in response to the event was not applicable. The outcome of the events, bloody nose, vomiting and the vomit had blood in it were considered as unknown.; Reporter's Comments: This report concerns a 61-year-old female who received Moderna's COVID-19 Vaccine (mRNA-1273, Lot number: 032L20A) and experienced bloody nose/epistaxis, vomiting and the vomit had blood in it/ hematemesis. Very limited information regarding these events has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1053575
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Unresponsive/laying in bed still; Sleepy and stayed in bed after getting vaccine; pale; eyes half open and foam coming from mouth; A spontaneous report was received from Pfizer concerning a 66 year old male who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced being unresponsive/laying in bed, sleepy and stayed in bed after getting vaccine, pale, and eyes half open and foam coming from mouth. The patient's medical history was not provided. Concomitant medication use was not provided. On an unknown date, the patient received unknown dose number of two planned doses of mRNA-1273 ([LOT number, route and location unknown]) for prophylaxis of COVID-19 infection. On an unknown date, the patient, who resided in a senior home, stayed in bed the dat after getting the vaccine. Early the next morning, he was observed in bed lying still, pale, eyes half open and foam coming from the mouth. He was unresponsive. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events of unresponsive/laying in bed still, sleepy and stayed in bed after getting vaccine, pale, and eyes half open and foam coming from mouth/ was unknown.; Reporter's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1053576
Sex: F
Age:
State: AR

Vax Date: 01/30/2021
Onset Date:
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lock down for dementia after first dose; A spontaneous report was received from a consumer concerning a female patient was participating in the mRNA-1273 Emergency Use Program and experienced lock down for dementia after first dose / dementia. The patient's medical history not provided. The patient's concomitant not provided. On 30th JAN 2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On unknown date, the patient was in lock down for dementia. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event, lock down for dementia after first dose, was not provided.; Reporter's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1053577
Sex: F
Age:
State:

Vax Date: 01/22/2021
Onset Date: 01/24/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot flashes, below the arm right side of the body, hot sensation on and off comes frequently; right hip pain; This is a spontaneous report from a contactable pharmacist. This pharmacist (patient) reported that a 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 22Jan2021 (past Friday night) at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 24Jan2021 (Sunday), patient experienced hot flashes, below the arm right side of the body, hot sensation on and off comes frequently. She also had right hip pain. Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1053578
Sex: F
Age:
State: TX

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The rash is up under arm, in armpit and is in the same arm of injection but there is no rash at the injection site.; because there was some itching under the arm. I went to see a dermatologist who says it has nothing to do with vaccine. I also had a slight headache; I also had a slight headache a day or two after the shot; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL3249, expiration date: unknown), via an unspecified route of administration on 14Jan2021 on left arm at a single dose for COVID-19 immunisation. Medical history included chronic kidney disease. The patient had chronic kidney disease and its real important for someone with her disease to get the vaccine, because if she got the actual virus it would hit the kidneys hard. The patient had no positive covid or antibody test prior to the vaccine. Concomitant medications were none. The patient stated that only thing she thinks would be related was that, she noticed this rather after using the hot tub, her husband just cleaned the hot tub and put chemicals in it, maybe she had a reaction to chemicals used to clean the hot tub. On 24Jan2021, the patient was reported after 10 days the patient had rash was up under the arm, near the arm pit, in the same arm of injection but there was no rash at the actual injection site, however her skin was beautiful, there was no spot except under the armpit. She got the injection a week ago Friday, she noticed the rash days later, on Sunday with itching under the arm. The Dermatologist says it has nothing to do with vaccine. The patient also had a slight headache a day or 2 (on 15Jan2021) after the shot, not a migraine, it was a slight dull headache, but went away. The patient went to the dermatologist yesterday, and he said it had nothing to do with the vaccine. She went to the dermatologist on 26Jan2021. Caller again stated that there was no rash at the injection site, but there was a rash underneath the arm in the arm pit. She still has it, she just started to use medicine last night. It's getting better. The Dermatologist prescribed a topical cream and its some kind of cortisone. The patient did not have any severe reaction like head swelling or swelling. The patient was scheduled for her second dose on 05Feb2021. The patient recovered from headache on 16Jan2021, recovering from rash, and for itching it was unknown.

Other Meds:

Current Illness:

ID: 1053579
Sex: F
Age:
State:

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: strong headaches; fever around 99.8 - 100 degree F; This is a spontaneous report from a non-contactable consumer. A female patient (reporter's wife) of an unspecified age receive BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 24Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that since Sunday morning, 24Jan2021, the patient has been suffering of strong headaches and fever. The patient experienced fever around 99.8 - 100 degree F and a very strong headache that cannot be controlled with medication. The outcome of the events was unknown. The events were reported as non-serious. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1053580
Sex: F
Age:
State: NJ

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Facial hives/hives on the face; might have caused a flare of my kidney disease; might have caused a flare of my kidney disease; This is a spontaneous report received from a contactable consumer (patient herself). A 26-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9264), via an unspecified route of administration on 27Jan2021 09:45 on left arm at single dose for COVID-19 immunisation. Medical history included liver transplant and kidney disease. The patient previously took amoxicillin and had allergies. The patient did not receive other vaccine in four weeks prior to vaccination but received other medications (unspecified) in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 27Jan2021 12:00, the patient experienced facial hives/hives on the face and reported that it might have caused a flare of my kidney disease. The seriousness of the events was considered as non-serious by the reporter. Therapeutic measures were taken as a result of event facial hives/hives on the face included Benadryl. The outcome of the event hives was recovering, whereas unknown for other events.

Other Meds:

Current Illness:

ID: 1053581
Sex: F
Age:
State: WI

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sever upper body itching; This is a spontaneous report from contactable nurse (patient). A 37-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL3248, expiry date unknown) in the hospital via an unspecified route of administration on 13Jan2021 at 10:00 at a single dose on the right arm for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included cetirizine hydrochloride (ZYRTEC). The patient previously took erythromycin and Polytrim and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe upper body itching on 13Jan2021. The itching started 7 hours after the vaccine. The patient received Benadryl, Zyrtec and Claritin as treatment. The patient recovered from the event. The event was reported as non-serious.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1053582
Sex: M
Age:
State: NM

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: unable to bear weight on legs/could not walk or bear weight; shortness of breath; fever; nausea/nauseous; pain in left shoulder radiating to left chest 4/10; Chest pain at the side 5/10; tried to get up to walk but was very shaky and could not get up to walk/unable to walk/could not walk or bear weight; dizzy/light headed; almost instantly was sharp stinging in injection site; tried to get up to walk but was very shaky and could not get up to walk; WBC 14000, no unit of measurement, normal was 11000; This is a spontaneous report received from a contactable pharmacist and consumer (patient). A 24-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: EL3302 and expiry date: May2021), via intramuscular route on deltoid left on 25Jan2021 15:57 at 0.3 ml single for COVID-19 immunization at hospital. Patient did not receive other vaccine in four weeks and in last two weeks. Patient's medical history, family medical history and concomitant medications were reported as none. Patient had no known allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number; EL1284; expiry date: Apr2021) via intramuscular route on left deltoid on 04Jan2021 at 10:45 AM for COVID-19 immunization; Hep B Adult Energix-BPFS (HEPATITIS B VACCINE, lot number; 2793Z) on left deltoid on 12Jan2021. Patient received 3 previous doses of HEPATITIS B VACCINE. It was reported that, the patient complained of pain in left shoulder radiating to left chest 4/10 and nausea immediately following injection, Chest pain at the side 5/10 (on 25Jan2021 at 14;00, after second dose of COVID vaccine). Taken to the ED (emergency department) via wheelchair at 1700. No rash, no swelling of lips/tongue or throat. No treatment was given for the events nausea and pain in left shoulder. No COVID was presented prior vaccination and post vaccination. Patient stated almost instantly was sharp stinging in injection site, he felt nauseous, dizzy, light headed, and had chest pains, he tried to get up to walk but was very shaky and could not get up to walk on25Jan2021 at 14:00. Stated that he was wheeled to the emergency room, he was admitted to the emergency room for almost 8 hours. Clarified he was not admitted to the hospital that he did leave that night. He was able to stumble out of the emergency room to go home. Clarified he got the vaccine on 25Jan2021 (his second dose). Stated he woke up next morning on 26Jan2021, unable to bear weight on legs, chest pain, and shortness of breath, fever. HCP prescribed Arnuity for the chest pain. WBC 14000, no unit of measurement, normal was 11000. Patient was unable to walk, nausea, dizzy, lightheaded and having some chest pain and patient was not hospitalized, spent 8 hours in Emergency Room. Outcome of the event fever was recovered on 27Jan2021; nausea, dizziness, was recovered on 31Jan2021; Unable to walk, lower extremities weakness of, shortness of breath was recovering; the event chest pain was not recovered; and for remaining events it was unknown.

Other Meds:

Current Illness:

ID: 1053583
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness at injection site of 3-4 inches; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced redness at injection site of 3-4 inches. The reporter wanted to know if there were any recommendations on how to treat this side effect. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1053584
Sex: F
Age:
State: CT

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slightly painful swollen lymph node on her left side near the clavicle and it was tender when touched; slightly painful swollen lymph node on her left side near the clavicle and it was tender when touched; This is a spontaneous report from a contactable consumer (patient herself). A 53-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3247), via an unspecified route of administration on the left arm, on 26Jan2021 13:00, at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not have COVID prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The vaccine was administered at the workplace clinic. The patient experienced having a slightly painful swollen lymph node on her left side near the clavicle and it was tender when touched on 27Jan2021 10:00. No treatment was received for the adverse events. The patient had not recovered from the adverse events at the time of the report. The patient has not been COVID tested post vaccination.

Other Meds:

Current Illness:

ID: 1053585
Sex: F
Age:
State: NJ

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tiredness; fever; This is a spontaneous report from a non-contactable consumer (patient). An adult female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 28Jan2021 at a single dose for COVID-19 immunization. The first dose was received on an unspecified date. The patient's medical history and concomitant medications were not reported. The patient experienced tiredness and fever on 28Jan2021 which resulted in a clinic visit. Outcome of the event was unknown. The reporter considered the events non-serious. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1053586
Sex: F
Age:
State: MI

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Difficulty lifting arm; horrible night sweats; This is a spontaneous report from a contactable consumer. An elderly female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on 27Jan2021 at a single dose for COVID-19 immunization. Medical history included covid-19 prior to vaccination. The patient's concomitant medications were not reported. The patient experienced difficulty lifting arm and horrible night sweats the night of injection (27Jan2021) and difficulty lifting arm the following morning. The patient was not tested for covid post vaccination. The outcome of the events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1053587
Sex: M
Age:
State: CT

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild pain started about 8h after vaccination with the COVID-19 vaccine at the side of vaccination (left arm); This is a spontaneous report from a contactable consumer (patient himself). A 38-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL3247, expiration date was unknown), via an unspecified route of administration in the left arm on 27Jan2021 at 13:00 at a single dose for COVID-19 immunization. The vaccine facility type was reported as the workplace clinic. The patient's medical history was not reported. The patient had no known allergies. There were no concomitant medications. The patient had no other vaccine in four weeks. The patient had no COVID-19 prior vaccination. The patient was not tested for COVID-19 post-vaccination. On 27Jan2021 at 21:00, the patient experienced mild pain started about 8 hours (8h) after vaccination with the COVID-19 vaccine at the side of vaccination (left arm). The patient did not receive any treatment for the adverse event (AE). The patient was recovering from the event.

Other Meds:

Current Illness:

ID: 1053588
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: palpitations; Fever of 101 (Degree)F; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration on unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her first dose of BNT162B2 (unknown lot number and expiration) for COVID-19 immunization on unspecified date. The patient called to report the side effects she experienced after administration of the second dose of the COVID-19 vaccine. She mentioned that 20 minutes after the administration of the second dose of the COVID-19 vaccine, she experienced palpitations and now she has a fever of 101 (Degree) F (unspecified dates). The patient was recommended by the nurse to manage fever with Tylenol. Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1053589
Sex: F
Age:
State: GA

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain on left side especially in her neck swelling at her left clavicle painful to touch; Pain on left side especially in her neck swelling at her left clavicle painful to touch; Pain on left side especially in her neck swelling at her left clavicle painful to touch; Pain on left side especially in her neck swelling at her left clavicle painful to touch; This is a spontaneous report from a contactable nurse (patient herself). A 58-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL3303, expiration date was unknown), intramuscularly in the left arm on 27Jan2021 at 12:30 at a single dose for COVID-19 immunization. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142, expiration date was unknown) on 06Jan2021 at 12:45 AM, intramuscularly in the left arm for COVID-19 immunization. The patient had no medical history. The patient had no known drug allergies (NKDA). There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Jan2021 at 06:00 AM, the patient experienced pain on left side especially in her neck swelling at her left clavicle painful to touch, which was assessed as non-serious. The patient did not receive any treatment for the adverse event. The patient was not recovered from the event.

Other Meds:

Current Illness:

ID: 1053590
Sex: F
Age:
State:

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: high fever/ranging from 100.4F-104.4F; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 27Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. It was reported that the patient has had a high fever since the vaccine dose on 27Jan2021, ranging from 100.4F-104.4F. She stated she is taking Tylenol for it and wants to know what else to do. The outcome of the event was unknown. The event was reported as non-serious. Information on the lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1053591
Sex: F
Age:
State: MO

Vax Date: 01/22/2021
Onset Date: 01/26/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe leg and hip pain; Severe leg and hip pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on 22Jan2021 09:00 (at the age of 57years) at single dose for Covid-19 immunization. Medical history included migraine. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included ibuprofen (ADVIL), levothyroxine sodium (SYNTHROID), amitriptyline, rizatriptan benzoate (MAXALT), and butalbital, caffeine, paracetamol (FIORICET); all taken from an unspecified date for an unspecified indication. The patient previously took compazine and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Jan2021 06:00, the patient experienced severe leg and hip pain. There was no treatment received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of events was not recovered. This case is non-serious.

Other Meds: ADVIL; SYNTHROID; AMITRIPTYLINE; MAXALT; FIORICET

Current Illness:

ID: 1053592
Sex: F
Age:
State: NY

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; headache; body aches; This is a spontaneous report from a contactable other healthcare professional (patient). A 34-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL8983) intramuscular on the left arm on 27Jan2021 08:30 at a single dose for Covid-19 immunization. Medical history included allergies, sinus (disorder), hearing loss and allergies: shellfish and sulfa. The patient previously received first dose of BNT162B2 on 04Jan2021 for COVID-19 immunization (first dose, 04:00 PM Intramuscular on the left arm lot number: EL 0142). Concomitant medication included nigella sativa (black seed oil), turmeric [curcuma longa rhizome] and multivitamins. On 28Jan2021 05:00 AM, the patient experienced fever, headache and body aches. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. Patient was not pregnant. The facility where the vaccine was administered was in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome of the events was unknown.

Other Meds: NIGELLA SATIVA; TURMERIC [CURCUMA LONGA RHIZOME]

Current Illness:

ID: 1053593
Sex: F
Age:
State:

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Fever; Body aches; Fatigue; stiffness in neck; This is a spontaneous report from a contactable nurse (patient). A 48-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date: unknown), via an unspecified route of administration on 26Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine 2 dose 2 days ago on Tuesday and from Tuesday night, she had pretty significant headache, fever, body aches, fatigue, and stiffness in neck. The patient wanted to know if that is normal and how long they last. The outcome of the events was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1053594
Sex: F
Age:
State: MN

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hot red face and neck; Hot red face and neck; possible slight swelling of face and eyes (minor); possible slight swelling of face and eyes (minor); chills; headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9264 and expiry date: unknown), via an unspecified route of administration on the left arm, on 29Jan2021 15:15 at a single dose for COVID-19 immunization. Medical history included hypertension and kidney disease, and was allergic to bee stings, penicillin, aluminum chloride. Patient was not pregnant at the of vaccination. There were unspecified medications received within 2 weeks of vaccination, and no other vaccine in 4 weeks prior to. The patient experienced hot red face and neck, possible slight swelling of face and eyes (minor), chills and headache on 29Jan2021 15:30. Outcome of the events was recovered. No treatment was received for the events. The reporter considered the events non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.

Other Meds:

Current Illness:

ID: 1053595
Sex: F
Age:
State: NC

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 02/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever 100-103; severe chills; body and joint aches; body and joint aches; weakness; fatigue; swollen lymph glands right armpit; sore injection site; This is a spontaneous report received from a contactable nurse (who is also the patient). A 59-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3247, expiry date: unknown), via an unspecified route of administration on the right arm, on 25Jan2021 12:30, at single dose, for COVID-19 immunization, at the workplace clinic. Medical history included penicillin allergy, hypertension (HTN), obesity, hypothyroidism, iron deficiency anemia, s/p gastric bypass in 2010 (11 years), and GERD. The patient was not pregnant at the time of vaccination. The patient did not have COVID-19 prior to vaccination. Concomitant medications (other medications in two weeks) included amlodipine benazapril, levothyroxine and pantoprazole. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL0140, expiry date: unknown) received at 59 years of age, via an unspecified route of administration on the left arm, on 04Jan2021 12:30, for COVID-19 immunization. The patient did not receive other vaccines in four weeks. On 26Jan2021 at 01:00, the patient experienced fever 100-103, severe chills, body and joint aches, weakness, fatigue, swollen lymph glands right armpit and sore injection site. The patient was not tested for COVID-19 post vaccination. No treatment was given for the events. The patient was recovering from the events.

Other Meds: AMLODIPINE BENAZEPRIL; LEVOTHYROXINE; PANTOPRAZOLE

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm